NCT06988956View on ClinicalTrials.gov

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG

Nimotuzumab

Nimotuzumab 400mg

DRUG

Tegafur

S-1 60mg/m2

RADIATION

radiotherapy

PTV 50Gy/2Gy

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER